Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance
- PMID: 22920535
- DOI: 10.2174/1874473711205030199
Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance
Abstract
In the nervous system, the interaction of opioids like morphine and its derivatives, with the G protein-coupled Mu-opioid receptor (MOR) provokes the development of analgesic tolerance, as well as physical dependence. Tolerance implies that increasing doses of the drug are required to achieve the same effect, a phenomenon that contributes significantly to the social problems surrounding recreational opioid abuse. In recent years, our understanding of the mechanisms that control MOR function in the nervous system, and that eventually produce opioid tolerance, has increased greatly. Pharmacological studies have identified a number of signaling proteins involved in morphine-induced tolerance, including the N-methyl-D-aspartate acid glutamate receptor (NMDAR), nitric oxide synthase (NOS), protein kinase C (PKC), protein kinase A (PKA), calcium (Ca²⁺)/calmodulin (CaM)-dependent kinase II (CaMKII), delta-opioid receptor (DOR) and the regulators of G-protein signaling (RGS) proteins. There is general agreement on the critical role of the NMDAR/nNOS/CaMKII pathway in this process, which is supported by the recent demonstration of a physical association between MORs and NMDARs in post-synaptic structures. Indeed, it is feasible that treatments that diminish morphine tolerance may target distinct elements within the same regulatory MOR-NMDAR pathway. Accordingly, we propose a model that incorporates the most relevant signaling components implicated in opioid tolerance in which, certain signals originating from the activated MOR are perceived by the associated NMDAR, which in turn exerts a negative feedback effect on MOR signaling. MOR- and NMDAR-mediated signals work together in a sequential and interconnected manner to ultimately induce MOR desensitization. Future studies of these phenomena should focus on adding further components to this signaling pathway in order to better define the mechanism underlying MOR desensitization in neural cells.
Similar articles
-
Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery?Curr Drug Abuse Rev. 2008 Jun;1(2):222-38. doi: 10.2174/1874473710801020222. Curr Drug Abuse Rev. 2008. PMID: 19630721 Review.
-
RGSZ2 binds to the neural nitric oxide synthase PDZ domain to regulate mu-opioid receptor-mediated potentiation of the N-methyl-D-aspartate receptor-calmodulin-dependent protein kinase II pathway.Antioxid Redox Signal. 2011 Aug 15;15(4):873-87. doi: 10.1089/ars.2010.3767. Epub 2011 May 19. Antioxid Redox Signal. 2011. PMID: 21348811
-
Brain-specific Galphaz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway.Cell Signal. 2009 Sep;21(9):1444-54. doi: 10.1016/j.cellsig.2009.05.003. Epub 2009 May 13. Cell Signal. 2009. PMID: 19446022
-
Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.PLoS One. 2010 Jun 23;5(6):e11278. doi: 10.1371/journal.pone.0011278. PLoS One. 2010. PMID: 20585660 Free PMC article.
-
The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.Eur J Pharmacol. 2013 Sep 15;716(1-3):94-105. doi: 10.1016/j.ejphar.2013.01.066. Epub 2013 Mar 13. Eur J Pharmacol. 2013. PMID: 23499699 Review.
Cited by
-
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity.Mol Brain. 2013 Oct 5;6:42. doi: 10.1186/1756-6606-6-42. Mol Brain. 2013. PMID: 24093505 Free PMC article.
-
The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders.Oncotarget. 2015 Nov 3;6(34):35458-77. doi: 10.18632/oncotarget.6064. Oncotarget. 2015. PMID: 26461475 Free PMC article.
-
Procyanidins alleviates morphine tolerance by inhibiting activation of NLRP3 inflammasome in microglia.J Neuroinflammation. 2016 Mar 1;13(1):53. doi: 10.1186/s12974-016-0520-z. J Neuroinflammation. 2016. PMID: 26931361 Free PMC article.
-
The Influence of Topiramate on Morphine Dependence in Mice.Biomolecules. 2025 May 16;15(5):730. doi: 10.3390/biom15050730. Biomolecules. 2025. PMID: 40427623 Free PMC article.
-
Repurposing EGFR Inhibitors for Oral Cancer Pain and Opioid Tolerance.Pharmaceuticals (Basel). 2023 Nov 3;16(11):1558. doi: 10.3390/ph16111558. Pharmaceuticals (Basel). 2023. PMID: 38004424 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous